Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The Significance and Reliability of Imaging Findings in Pseudotumor Cerebri.

Delen F, Peker E, Onay M, Altay ÇM, Tekeli O, Togay Işıkay C.

Neuroophthalmology. 2018 Jul 19;43(2):81-90. doi: 10.1080/01658107.2018.1493514. eCollection 2019 Apr.

2.

Investigation of the Presence of Glaucoma in Patients with Obstructive Sleep Apnea Syndrome Using and Not Using Continuous Positive Airway Pressure Treatment

Abdullayev A, Tekeli O, Yanık Ö, Acıcan T, Gülbay B.

Turk J Ophthalmol. 2019 Jun 27;49(3):134-141. doi: 10.4274/tjo.galenos.2018.88614.

3.

Evaluation of the retinal nerve fiber layer and ganglion cell complex thicknesses in patients with exfoliation syndrome

Alay C, Tekeli O, Yanık Odabaş Ö, Çalış Karanfil F.

Turk J Med Sci. 2019 Feb 11;49(1):272-278. doi: 10.3906/sag-1803-27.

PMID:
30761874
4.

Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.

Selen F, Tekeli O, Yanık Ö.

J Ocul Pharmacol Ther. 2017 Apr;33(3):170-175. doi: 10.1089/jop.2016.0128. Epub 2017 Feb 6.

PMID:
28165835
5.

Optic disc area in different types of glaucoma.

Tekeli O, Savku E, Abdullayev A.

Int J Ophthalmol. 2016 Aug 18;9(8):1134-7. doi: 10.18240/ijo.2016.08.08. eCollection 2016.

6.

Comparison of efficacy of chemical peeling with 25% trichloroacetic acid and 0.1% retinoic acid for facial rejuvenation.

Yildirim S, Gurel MS, Gungor S, Tekeli O, Canat D.

Postepy Dermatol Alergol. 2016 Jun;33(3):199-205. doi: 10.5114/ada.2016.60612. Epub 2016 Jun 17.

7.

A model for managing and monitoring the quality of glucometers used in a high-volume clinical setting.

Aykal G, Yegin A, Tekeli Ö, Yilmaz N.

Biochem Med (Zagreb). 2016;26(2):202-9. doi: 10.11613/BM.2016.022.

8.

Periocular changes in topical bimatoprost and latanoprost use.

Karslioğlu MZ, Hoşal MB, Tekeli O.

Turk J Med Sci. 2015;45(4):925-30.

PMID:
26422869
9.

Identification of an IGSF3 mutation in a family with congenital nasolacrimal duct obstruction.

Foster J 2nd, Kapoor S, Diaz-Horta O, Singh A, Abad C, Rastogi A, Moharana R, Tekeli O, Walz K, Tekin M.

Clin Genet. 2014 Dec;86(6):589-91. doi: 10.1111/cge.12321. Epub 2013 Dec 27. No abstract available.

PMID:
24372406
10.

SLITRK6 mutations cause myopia and deafness in humans and mice.

Tekin M, Chioza BA, Matsumoto Y, Diaz-Horta O, Cross HE, Duman D, Kokotas H, Moore-Barton HL, Sakoori K, Ota M, Odaka YS, Foster J 2nd, Cengiz FB, Tokgoz-Yilmaz S, Tekeli O, Grigoriadou M, Petersen MB, Sreekantan-Nair A, Gurtz K, Xia XJ, Pandya A, Patton MA, Young JI, Aruga J, Crosby AH.

J Clin Invest. 2013 May;123(5):2094-102. doi: 10.1172/JCI65853. Epub 2013 Apr 1.

11.

Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma.

Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH.

Mol Vis. 2008;14:1815-8. Epub 2008 Sep 30.

12.

Bevacizumab sterility in multiple doses from a single-use vial.

Ornek K, Karahan ZC, Ergin A, Tekeli A, Tekeli O.

Ann Pharmacother. 2008 Oct;42(10):1425-8. doi: 10.1345/aph.1L270. Epub 2008 Sep 2.

PMID:
18765834
13.

Evaluation of the optic nerve head with the heidelberg retina tomograph in diabetes mellitus.

Tekeli O, Turaçli ME, Atmaca LS, Elhan AH.

Ophthalmologica. 2008;222(3):168-72. doi: 10.1159/000126079. Epub 2008 May 22.

PMID:
18497525
14.

No relation between angiotensin-converting enzyme gene polymorphism and pseudoexfoliation.

Tekeli O, Turaçli ME, Altinok B, Akar N, Elhan AH.

Ophthalmic Res. 2008;40(1):32-4. Epub 2006 Nov 27.

PMID:
18025834
15.

Sensorineural hearing loss in pseudoexfoliation.

Turacli ME, Ozdemir FA, Tekeli O, Gökcan K, Gerçeker M, Dürük K.

Can J Ophthalmol. 2007 Feb;42(1):56-9.

PMID:
17361242
16.

Changes in electrical and physiological properties of human blood during storage.

Sezdi M, Sonmezoglu M, Tekeli O, Ulgen Y, Emerk K.

Conf Proc IEEE Eng Med Biol Soc. 2005;7:6710-3.

PMID:
17281812
17.

Pattern electroretinography and visual evoked potentials in optic nerve diseases.

Atilla H, Tekeli O, Ornek K, Batioglu F, Elhan AH, Eryilmaz T.

J Clin Neurosci. 2006 Jan;13(1):55-9.

PMID:
16410198
18.

Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation.

Turaçli ME, Tekeli O, Ozdemir F, Akar N.

Clin Exp Ophthalmol. 2005 Oct;33(5):505-8.

PMID:
16181277
19.

Anterior megalophthalmos with pigmentary glaucoma.

Turaçli ME, Tekeli O.

Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):1066-8. Epub 2005 Oct 20.

PMID:
15838662
20.

Acute optic neuropathy in Behçet disease.

Yalçindag N, Yilmaz N, Tekeli O, Ozdemir O.

Eur J Ophthalmol. 2004 Nov-Dec;14(6):578-80.

PMID:
15638113
21.

Infantile glaucoma in a patient with Rothmund-Thomson syndrome.

Turaçli ME, Tekeli O.

Can J Ophthalmol. 2004 Oct;39(6):674-8. No abstract available.

PMID:
15559657
22.

Acute optic neuropathy in Behet disease.

Yalcindag N, Yilmaz N, Tekeli O, Ozdemir O.

Eur J Ophthalmol. 2004 Nov - Dec 2004;14(6):578-580. doi: 10.5301/EJO.2008.950.

PMID:
28221664
23.

Limbal autograft and allograft transplantations in patients with corneal burns.

Ozdemir O, Tekeli O, Ornek K, Arslanpençe A, Yalçindağ NF.

Eye (Lond). 2004 Mar;18(3):241-8.

PMID:
15004571
24.

Alpha-melanocyte stimulating hormone has beneficial effects on cerulein-induced acute pancreatitis.

Jahovic N, Arbak S, Tekeli O, Alican I.

Peptides. 2004 Jan;25(1):129-32.

PMID:
15003365
25.

Heidelberg retina tomograph in ocular Behçet's disease.

Tekeli O, Ozdemir O.

Eye (Lond). 2004 Feb;18(2):143-6.

PMID:
14762405
26.

Quantitative lacrimal scintigraphy after dacryocystorhinostomy.

Zilelioglu G, Küçük O, Tekeli O, Günan F, Aras G.

Ophthalmic Surg Lasers Imaging. 2004 Jan-Feb;35(1):37-40.

PMID:
14750762
27.

Effects of intracameral lidocaine on ocular tissues.

Atilla H, Tekeli O, Can B, Karel F, Saran Y.

Clin Exp Ophthalmol. 2003 Feb;31(1):73-7.

PMID:
12580899
28.

Anterior uveitis and Sjögren's syndrome in a patient with primary biliary cirrhosis.

Tekeli O, Ozdemir O.

Can J Ophthalmol. 2002 Oct;37(6):359-60. No abstract available.

PMID:
12422919
29.

Results of endoscopic endonasal non-laser dacryocystorhinostomy.

Zílelíoğlu G, Tekeli O, Uğurba SH, Akiner M, Aktürk T, Anadolu Y.

Doc Ophthalmol. 2002 Jul;105(1):57-62.

PMID:
12152803
30.

The role of enophthalmos in the development of involutional ectropion.

Hosal BM, Tekeli O, Gürsel E.

Orbit. 1999 Mar;18(1):7-9.

PMID:
12048692
31.
32.

Risk factors for vitreous loss in cataract surgery.

Abbasoğlu OE, Hoşal B, Tekeli O, Gürsel E.

Eur J Ophthalmol. 2000 Jul-Sep;10(3):227-32.

PMID:
11071030
33.

A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery.

Abbasoğlu E, Tekeli O, Celikdoğan A, Gürsel E.

Eur J Ophthalmol. 2000 Jan-Mar;10(1):27-31.

PMID:
10744202
34.

Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.

Tekeli O, Gürsel E, Buyurgan H.

Acta Ophthalmol Scand. 1999 Dec;77(6):628-30.

35.

Divergence paralysis & intracranial hypertension due to neurobrucellosis. A case report.

Tekeli O, Tomaç S, Gürsel E, Hasiripi H.

Binocul Vis Strabismus Q. 1999;14(2):117-8.

PMID:
10506689
36.

Eyelid malpositions after cataract surgery.

Hosal BM, Tekeli O, Gürsel E.

Eur J Ophthalmol. 1998 Jan-Mar;8(1):12-5.

PMID:
9590589

Supplemental Content

Loading ...
Support Center